OtherCardiovascular
Pharmacological characterization of BM-573, a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding time
Jean-Michel PN Dogne, Julien Hanson, Xavier de Leval, Vincent Tchana-Sato, Philippe Kolh, Laurence de Leval, Stephanie Rolin, Alexandre Ghuysen, Patrick Segers, Bernard Lambermont, Bernard Masereel and Bernard Pirotte
Journal of Pharmacology and Experimental Therapeutics January 23, 2004, DOI: https://doi.org/10.1124/jpet.103.063610
Jean-Michel PN Dogne
Julien Hanson
Xavier de Leval
Vincent Tchana-Sato
Philippe Kolh
Laurence de Leval
Stephanie Rolin
Alexandre Ghuysen
Patrick Segers
Bernard Lambermont
Bernard Masereel
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherCardiovascular
Pharmacological characterization of BM-573, a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding time
Jean-Michel PN Dogne, Julien Hanson, Xavier de Leval, Vincent Tchana-Sato, Philippe Kolh, Laurence de Leval, Stephanie Rolin, Alexandre Ghuysen, Patrick Segers, Bernard Lambermont, Bernard Masereel and Bernard Pirotte
Journal of Pharmacology and Experimental Therapeutics January 23, 2004, DOI: https://doi.org/10.1124/jpet.103.063610
OtherCardiovascular
Pharmacological characterization of BM-573, a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding time
Jean-Michel PN Dogne, Julien Hanson, Xavier de Leval, Vincent Tchana-Sato, Philippe Kolh, Laurence de Leval, Stephanie Rolin, Alexandre Ghuysen, Patrick Segers, Bernard Lambermont, Bernard Masereel and Bernard Pirotte
Journal of Pharmacology and Experimental Therapeutics January 23, 2004, DOI: https://doi.org/10.1124/jpet.103.063610
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement